Industry Insights
-
How To Set Up An Effective Quality Risk Management Program
2/16/2022
The author of this article has taught courses on quality risk management (QRM) and its implementation as well as seen it in action in many companies. This article, Part 1 of a 2-part series, shares some of his observations and lessons learned in setting up an effective QRM program.
-
Continuous Manufacturing: Why Isn’t It Ubiquitous Yet? (When It Should Be)
10/5/2018
The question is no longer, “Will continuous manufacturing work?”, but “When will everyone be doing it?” But surprisingly, there are still many objections to continuous manufacturing within the biopharma industry.
-
21st Century Cures & FDA Implementation: 5 Important Takeaways For Biopharma Companies
12/21/2016
Now that the 21st Century Cures bill has been signed into law — following a nearly three- year journey that included a fair number of detours and roadblocks — all eyes in the drug development world are shifting to FDA. To the question “What now?” FDA can answer: A great deal of work.
-
Who Will Win The Regenerative Medicine For Diabetes Race?
1/10/2019
Regenerative medicine could be a game-changing approach to meet the needs of insulin-dependent patients. Although the field is still in its infancy, the initial clinical data looks promising. This article takes a closer look at a few innovative companies that are racing to bring the first regenerative medicine for diabetes to the market.
-
Big Data Solutions: Tips For Selection And Implementation
4/4/2016
The health care marketplace is growing at an ever-increasing pace. It’s projected that total global spending on medicines will increase by 30 percent and top $1.3T by 2018 and that more than 400 Life Sciences products will be launched over the next three years.
-
6 Strategies To Protect Your Biologics Supply Chain In 2023
1/25/2023
Instead of automating everything — which costs a lot and doesn't solve every problem — drug makers should focus on building scalable, need-specific supply chain operations. This article discusses supply chain resilience strategies biotech companies can reasonably control.
-
In 2023, What Trends Will Dominate Cybersecurity?
1/26/2023
Explore 2023 cybersecurity predictions regarding incidence response, cyberattackers, SMBs, and more. Additionally, discover practical resources that you can review to improve your cyber preparedness.
-
CM Partnering For Adaptable, Accelerated Market Acceptance
8/16/2022
The need for manufacturing support that offers adaptable, scalable solutions has become more crucial than ever for the diagnostic space.
-
Pacesetters Are Product Innovators Who Embrace Digital Process Enhancement
12/12/2023
The Josh Bersin Company recently underwent research examining pharma/biotech “pacesetters” in the field. We caught up with Jordan Schmitting, senior research analyst at The Josh Bersin Company, to discuss the trends illuminated by the research.
-
Medtech In Chile: Currently Latin America’s Easiest Market, But For How Long?
6/16/2021
The total market size of the medical device sector in Chile is about $1.7 billion and has grown a whopping 75 percent since 2017. The nation imports most of its medical devices, and it currently has the easiest regulatory hurdles for medtech in Latin America. However, you should prepare for the upcoming bill that may impact regulation.